Improving Access to Clinical Trials Act of 2009

HR 2366, The Cancer Coverage Parity Act S1674/HR2866- Improving Access to Clinical Trials Cancer specific issues related to the forthcoming proposed rule on the essential health benefits package

Client expense: $58,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Advocate for outpatient payment update under the Outpatient Prospective Payment System for dedicated cancer centers. Support enactment of Improving Access to Clinical Trials Act of 2010 -- S.1674.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues relating to prescription drugs in health care bills; H.R. 4213; War supplemental; H.R. 4899; H.R. 5712; the Veterans' Seniors and Children's Health Technical Corrections Act of 2010; Baucus extenders bill; drug disposal bills; orphan drug and rare disease bills; S.3697 Creating Hope Act; S.1674, Improving Access to Clinical Trials Act of 2010.

Client expense: Not reported · Firm income: $80,000

Government targets: Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, SENATE

HRes 1433 Resolution Designating September, 2010, Blood Cancer Awareness Month S1674/ HR 2866 Improving Access to Clinical Trials HR 2366 The Cancer Coverage Parity Act

Client expense: $57,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Improving Access to Clinical Trials Act, HR 2866/S 1674

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 2366 - Cancer Coverage Parity H Res 1433 - Resolution designating September 2010 as Blood Cancer Awareness Month S 717 - Cancer Alert Act S 1674 / HR 2866 - Improving Access to Clinical Trials Act

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Marfan Syndrome Research and Education Programs at NIH and CDC S. 1674 & H.R. 2866: "Improving Access to Clinical Trials Act"

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

Improving Access to Clinical Trials Act, HR 2466/S 1674

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Marfan Syndrome Research and Education Programs at NIH and CDC S. 1674 & H.R. 2866: "Improving Access to Clinical Trials Act"

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

HR 3590 Patient Protection and Affordable Care Act HR 2866/S 1674 Iproving Access to Clinical Trials Act HR 2560.S 1131 Independence at Home Act HR 4272/S 1206 Pediatric Workforce Investment Act

Client expense: $25,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Improving Access to Clinical Trials Act, HR 2466/S 1674

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 2866 and S. 1674 "Improving Access to Clinical Trials Act of 2009," Appropriations/ NIH & AHRQ, health reform, organ allocations, UNOS - Organ Allocations, Federal funding for research

Client expense: $31,198 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), President of the U.S., SENATE, Social Security Administration (SSA), White House Office

H.R. 2866 and S. 1674 "Improving Access to Clinical Trials Act of 2009," Appropriations/ NIH & AHRQ, health reform, organ allocations, UNOS - Organ Allocations, Federal funding for research

Client expense: $31,198 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), President of the U.S., SENATE, Social Security Administration (SSA), White House Office

H.R. 2866 and S. 1674 "Improving Access to Clinical Trials Act of 2009," Appropriations/ NIH & AHRQ, health reform, organ allocations, UNOS - Organ Allocations, Federal funding for research

Client expense: $31,198 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), President of the U.S., SENATE, Social Security Administration (SSA), White House Office

Improving Access to Clinical Trials Act (HR 2466/S 1674)

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 1030 & S 2803: Tom Lantos Pulmonary Hypertension Research and Education Act HR 1558 & S 623: Pre-existing Condition Patient Protection Act Pulmonary Hypertension Research Prog. at NIH HR 1085 & S 442: Health Insurance Coverage Protection Act Health Ins. Reform Legislation HR 1708 & S 700: Ending the Medicare Disability Waiting Period Act of 2009 H.R. 2866, Improving Access to Clinical Trials Act S. 1674, Improving Access to Clinical Trials Act H.R. 3200, America's Affordable Health Care Choices Act S. 1679, Affordable Health Choices Act H.R. 3962, Affordable Health Care for America Act H.R. 3590, Patient Protection and Affordable Care Act

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

HR 1558 & S 623: Pre-existing Condition Patient Protection Act HR 2866, Improving Access to Clinical Trials Act HR 1708 & S 700: Ending the Medicare Disability Waiting Period Act S 1674, Improving Access to Clinical Trials Act HR 1085 & S 442: Health Insurance Coverage Protection Act HR 3200, America's Affordable Health Care Choices Act Marfan Syndrome Research and Education Programs at NIH S 1679, Affordable Health Choices Act HR 3962, Affordable Health Care for America Act HR 3590, Patient Protection and Affordable Care Act

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 3200, the America's Affordable Health Choices Act of 2009, S. 1679 Affordable Health Choices Act of 2009, the Senate's America's Healthy Future Act -- provisions in all three related to hospitals, children's hospitals, children's health, and pediatric workforce issues. S. 621, the Congenital Heart Futures Act, all provisions, S. 1674 and H.R. 2866, Improving Access to Clinical Trials Act of 2009.

Client expense: $111,383 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Improving Access to Clinical Trials Act of 2009, H.R. 2866/S.1674

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 2866 and S. 1674 "Improving Access to Clinical Trials Act of 2009," Appropriations/ NIH & AHRQ, health reform, organ allocations

Client expense: $30,187 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), President of the U.S., SENATE, Social Security Administration (SSA), White House Office

HR 1558 & S 623: Pre-existing Condition Patient Protection Act Health Insurance Reform Legislation HR 1708 & S 700: Ending the Medicare Disability Waiting Period Act HR 1085 & S 442: Health Insurance Coverage Protection Act Marfan Syndrome Research and Education Programs at NIH H.R. 2866, Improving Access to Clinical Trials Act S. 1674, Improving Access to Clinical Trials Act H.R. 3200, America's Affordable Health Care Choices Act S. 1679, Affordable Health Choices Act S., America's Health Futures Act of 2009

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 1030: Tom Lantos Pulmonary Hypertension Research and Education Act Health Ins. Reform Legislation HR 1558 & S 623: Pre-existing Condition Patient Protection Act Pulmonary Hypertension Research Prog. at NIH HR 1085 & S 442: Health Insurance Coverage Protection Act HR 1708 & S 700: Ending the Medicare Disability Waiting Period Act of 2007 H.R. 2866, Improving Access to Clinical Trials Act S. 1674, Improving Access to Clinical Trials Act H.R. 3200, America's Affordable Health Care Choices Act S. 1679, Affordable Health Choices Act S., America's Health Futures Act of 2009

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

House and Senate FY 10 Labor-HHS-Education Appropriations Bills (Research and Disease Prevention Programs) H.R. 2866, Improving Access to Clinical Trials Act S. 1674, Improving Access to Clinical Trials Act H.R. 3200, America's Affordable Health Care Choices Act S. 1679, Affordable Health Choices Act S., America's Health Futures Act of 2009

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE